CLINICAL_TRIALS
trial_result
· 2014-07-14
Clinical Trial Update: A Study in Participants With Diabetic Peripheral Neuropathic Pain in China [Phase 3]
Summary
A Phase 3 study in China evaluating a treatment for painful diabetic neuropathy sponsored by Eli Lilly and Company has completed and posted results in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetic Neuropathy, Painful | Phase 3 | Status: COMPLETED | Results posted: 2014-07-14